0000000001252821

AUTHOR

C Morgan

EXPLORING SPECIFIC EFFECTS OF TYPE AND TIMING OF EXPOSURE TO CHILDHOOD ADVERSITY AND SYMPTOM DOMAINS IN FIRST EPISODE OF PSYCHOSIS: PRELIMINARY RESULTS FROM THE EUGEI PROJECT

research product

ENVIRONMENTAL RISK FACTORS DIFFERENCES AMONG DIAGNOSTIC CATEGORIES IN EU-GEI STUDY

research product

Gene X cannabis interaction: Case-only design analysis in a first-episode psychosis sample

research product

Interaction between cannabis consumption and childhood abuse in psychotic disorders:preliminary findings on the role of different patterns of cannabis use

Aim: Several studies have suggested that lifetime cannabis consumption and childhood abuse synergistically contribute to the risk for psychotic disorders. This study aimed to extend existing findings regarding an additive interaction between childhood abuse and lifetime cannabis use by investigating the moderating role of type and frequency of cannabis use. Methods: Up to 231 individuals presenting for the first time to mental health services with psychotic disorders and 214 unaffected population controls from South London, United Kingdom, were recruited as part of the Genetics and Psychosis study. Information about history of cannabis use was collected using the Cannabis Experiences Questi…

research product

Educational achievement, cannabis use, and genotype in predicting psychosis

research product

COGNITION, METACOGNITION AND SOCIAL COGNITION AFTER A FIRST EPISODE PSYCHOSIS. PRELIMINARY RESULTS FROM A 5-YEAR-FOLLOW-UP STUDY

research product

Is cerebral asymmetry associated with serotonin transporter in psychosis?

research product

First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data

Abstract Cluster studies identified a subgroup of patients with psychosis whose premorbid adjustment deteriorates before the onset, which may reflect variation in genetic influence. However, other studies reported a complex relationship between distinctive patterns of cannabis use and cognitive and premorbid impairment that is worthy of consideration. We examined whether: (1) premorbid social functioning (PSF) and premorbid academic functioning (PAF) in childhood and adolescence and current intellectual quotient (IQ) define different clusters in 802 first-episode of psychosis (FEP) patients; resulting clusters vary in (2) polygenic risk scores (PRSs) for schizophrenia (SCZ_PRS), bipolar dis…

research product

PREVALENCE OF BULLYING AMONGST FIRST-EPISODE PSYCHOSIS PATIENTS AND UNAFFECTED CONTROLS

Background:Despite increasing evidence suggesting that childhood mal-treatment is significantly associated with psychotic disorders, the role ofbullying in the later development of psychosis is still controversial (Kelle-her et al., 2008, Arseneault et al., 2011). Therefore, this study examinedthe prevalence of bullying amongst first-episode psychosis patients andunaffected controlsMethods:Data were collected from 227 first-presentation psychosis casesand 215 geographically-matched controls. Bullying was assessed as partof the Brief Life Events schedule. Patients and controls were shown acard listing 10 adverse events, including “bullying”, “sexual abuse”, “beingexpelled from school”, and a…

research product

DOES CANNABIS USE WORSEN PSYCHOTIC SYMPTOM PRESENTATION?

Background: While the relationship between cannabis and psychosis is well established, there is a lack of studies into whether cannabis use is associated with a particular pattern of symptoms at psychosis onset. Moreover, there is much evidence that psychotic experiences are common in the healthy population, and again their relationship with exposure to cannabis has been scarcely studied. We hypothesized that psychopathology in first-episode psychosis patients (FEP), and psychotic experiences in controls, would be qualitatively and quantitatively affected by pattern of cannabis use. Methods: The Operational CRITeria (OPCRIT) system, the CAPE (Community Assessment of Psychic Experiences), an…

research product

A first episode psychosis case-control genetic association study

Background:GAP(genesandpsychosis) is a case-control studyof first episode psychosis conducted in London and Cambridge, which aims to identify genes conferring susceptibility to psychosis, and associated phenotypes including cognitive dysfunction and cerebral morphology. Methods:First episode psychosis cases have been recruited in South London and Maudsley NHS Trust and in Cambridge. A variety of demographic and clinical data have been collected. In a subset of these, neurocognitive assessments and MRIs have been performed. Samples have been taken for DNA, and in a subset for RNA and proteomic analysis. Genetic association analysis is being undertaken using a candidate gene approach. The gen…

research product

THE ROLE OF CHILDHOOD TRAUMA AND COGNITIVE DEFICIT IN MODERATING THE RISK FOR PSYCHOTIC DISORDERS: A COMPARISON BETWEEN PALERMO AND SOUTH-EAST LONDON FIRST EPISODE PSYCHOSIS (FEP) SAMPLES

research product

DNA METHYLATION PROFILING MIGHT SHED LIGHT ON THE BIOLOGY OF CANNABIS ASSOCIATED PSYCHOSIS

research product

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study

The work was supported by: Clinician Scientist Medical Research Council fellowship (project reference MR/M008436/1) to MDF; the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King’s College Hospital NHS Foundation Trust to DQ; DFG Heisenberg professorship (no. 389624707) to UR. National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The EU-GEI Project is funded by t…

research product

GENE AND ENVIRONMENT INTERPLAY AMONG DIAGNOSTIC CATEGORIES IN THE EUGEI STUDY

research product